Author

Halyna Wysowskyj

Observed name: H. Wysowskyj

Institution: Stemline Therapeutics (United States)

Observed institution: Stemline Therapeutics (United States)

OpenAlex ID: A5088730771

Results from a Phase 1/2 Clinical Trial of Tagraxofusp (SL-401) in Patients with Intermediate, or High Risk, Relapsed/Refractory Myelofibrosis

2019 · Naveen Pemmaraju, Vikas Gupta, et al. · Blood · 23

Regulation of Central Cholecystokinin Recognition Sites by Guanyl Nucleotides

1988 · L. Wennogle, H. Wysowskyj, et al. · Journal of Neurochemistry · 23

Results from Ongoing Phase 1/2 Clinical Trial of Tagraxofusp (SL-401) in Patients with Relapsed/Refractory Chronic Myelomonocytic Leukemia (CMML)

2018 · Mrinal M. Patnaik, Haris Ali, et al. · Blood · 15

Results from ongoing phase 1/2 clinical trial of tagraxofusp (SL-401) in patients with relapsed/refractory chronic myelomonocytic leukemia (CMML).

2019 · Mrinal Mahesh Patnaik, Haris Ali, et al. · Journal of Clinical Oncology · 10

Results from Ongoing Phase 1/2 Clinical Trial of Tagraxofusp (SL-401) in Patients with Intermediate or High Risk Relapsed/Refractory Myelofibrosis

2018 · Naveen Pemmaraju, Vikas Gupta, et al. · Blood · 9

Results from ongoing phase 1/2 clinical trial of tagraxofusp (SL-401) in patients with intermediate or high risk relapsed/refractory myelofibrosis.

2019 · Naveen Pemmaraju, Haris Ali, et al. · Journal of Clinical Oncology · 8

Pf668 Results From Ongoing Phase 1/2 Clinical Trial of Tagraxofusp (sl‐401) in Patients With Intermediate, or High Risk, Relapsed/refractory Myelofibrosis

2019 · N. Pemmaraju, H. Ali, et al. · HemaSphere · 5

Results from Phase 1/2 Trial of Tagraxofusp in Combination with Pomalidomide and Dexamethasone in Relapsed or Refractory Multiple Myeloma

2019 · Paul G. Richardson, Myo Htut, et al. · Blood · 4

Pf672 Results From Ongoing Phase 1/2 Clinical Trial of Tagraxofusp (sl‐401) in Patients With Relapsed/refractory Chronic Myelomonocytic Leukemia (cmml)

2019 · M. Patnaik, H. Ali, et al. · HemaSphere · 1

Modulation of central cholecystokinin receptors by guanyl nucleotides

1985 · Lawrence P. Wennogle, Halyna Wysowskyj, et al. · The Society for Neuroscience Abstracts

Works count: 10

Citation count: 98

H-index: 6

I10-index: 4